Home › Melanoma › North Carolina › Asheville
Melanoma clinical trials in Asheville, NC
3 studies for Melanoma are looking for participants at sites in and around Asheville (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- AdventHealth Infusion Center Asheville, Asheville
- AdventHealth Infusion Center Weaverville, Weaverville · 7 mi away
- AdventHealth Hendersonville, Hendersonville · 20 mi away
- and 1 more
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
RecruitingPhase 3
- Messino Cancer Center, Asheville
Project: Every Child for Younger Patients With Cancer
RecruitingObservational study
- Mission Hospital, Asheville
About Melanoma
Melanoma is the most serious type of skin cancer. Most have a black or black-blue area. Learn the 'ABCDE' of what to watch for and treatment options.
More about Melanoma on MedlinePlus
Melanoma trials in other cities
- Houston, TX59 studies
- New York City, NY38 studies
- Los Angeles, CA34 studies
- Nashville, TN33 studies
- Pittsburgh, PA31 studies
- Boston, MA26 studies
- Philadelphia, PA23 studies
- San Francisco, CA22 studies
- St. Louis, MO21 studies
- Durham, NC21 studies
- Salt Lake City, UT21 studies
- Columbus, OH21 studies
Other studies in Asheville
- Heart Failure7 studies
- Non-Small Cell Lung Cancer5 studies
- Acute Lymphoblastic Leukemia4 studies
- Acute Myeloid Leukemia4 studies
- Chronic Lymphocytic Leukemia4 studies
- Burkitt Lymphoma4 studies
- Cardiovascular Disease4 studies
- Lung Cancer4 studies
- Acute Biphenotypic Leukemia3 studies
- Graves Disease3 studies
- Hyperthyroidism3 studies
- Colorectal Cancer3 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.